Laparascopic TAP and Hysterectomy Trial #2
TAP2
Laparoscopically Assisted Transversus Abdominis Plane Block Using Liposomal Bupivacaine and Laparoscopic or Robotic Gynecology: A Randomized Controlled Trial (#2)
1 other identifier
interventional
32
0 countries
N/A
Brief Summary
More than 600,000 hysterectomies are performed in the United States each year, making it the most common non-obstetric major surgery performed on women1. Estimates suggest that at least 30% of hysterectomies are performed laparoscopically or robotically with an increasing trend toward minimally invasive approaches2. While a minimally invasive approach certainly provides improved recovery, patients still experience substantial pain and most require opiate medications for pain control. Incorporating a multimodal approach to postoperative pain management through the use of field nerve blocks is potentially an ideal way to enhance recovery and minimize the need for narcotic pain medications. Over the past decade, the use of Transversus Abdominis Plane (TAP) blocks as an adjunct for postoperative pain management has gained in popularity. First described in 2001 by Dr. Rafi of Limerick3, Ireland, TAP blocks are now typically performed by an anesthesiologist with the use of ultrasound guidance. The transversus abdominis plane is the neurovascular plane between the aponeurosis of the internal oblique and transversus abdominis muscles. Herein lie the afferent nociceptor nerve endings of T7-L1. Injection of a 20-30cc volume of anesthetic into this plane causes a sensory nerve block to the ipsilateral antero-abdominal wall from the costal margin to the symphysis pubis4. Clinical trials have documented the validity of using TAP blocks for both open and laparoscopic procedures and verified their use for postsurgical pain relief. Studies have demonstrated that TAP blocks for both open and laparoscopic hysterectomies are safe and efficacious5, 6. In 2011, De Oliveira et al. demonstrated improved quality of recovery for women undergoing preoperative ultrasound guided TAP infiltration with ropivacaine at the time of laparoscopic hysterectomy7.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2017
CompletedFirst Submitted
Initial submission to the registry
May 2, 2018
CompletedFirst Posted
Study publicly available on registry
October 19, 2018
CompletedOctober 19, 2018
May 1, 2018
1.2 years
May 2, 2018
October 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall Benefit of Anesthesia Score (OBAS)
Change in resting pain, vomiting, itching, sweating, freezing, dizziness, satisfaction Likert 0-10 0=not at all, 10- very much
Post operative day 7
Secondary Outcomes (2)
OBAS Questionnaire
Post operative day 1
OBAS Questionnaire
Post operative day 2
Study Arms (2)
TAP block of 10cc Liposomal bupivacaine
ACTIVE COMPARATORPatients in this arm of the study would receive a bilateral Laparoscopic Assisted TAP block with 10cc Liposomal bupivacaine, 10cc 0.25% bupivacaine and 10cc normal saline each bilaterally at the beginning of their surgery.
Routine pre-incisional injections at trocar incision sites
NO INTERVENTIONThe patients in the control arm of the study would receive routine pre-incisional injections at the trocar incision sites using a total of 20cc 0.25% bupivacaine.
Interventions
Eligibility Criteria
You may qualify if:
- adult women
- undergoing laparoscopic robotic assisted laparoscopic hysterectomy with or without removal of adnexa
You may not qualify if:
- \< 18
- Not undergoing laparoscopic hysterectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (7)
De Oliveira GS Jr, Milad MP, Fitzgerald P, Rahmani R, McCarthy RJ. Transversus abdominis plane infiltration and quality of recovery after laparoscopic hysterectomy: a randomized controlled trial. Obstet Gynecol. 2011 Dec;118(6):1230-1237. doi: 10.1097/AOG.0b013e318236f67f.
PMID: 22105251BACKGROUNDJacobson GF, Shaber RE, Armstrong MA, Hung YY. Hysterectomy rates for benign indications. Obstet Gynecol. 2006 Jun;107(6):1278-83. doi: 10.1097/01.AOG.0000210640.86628.ff.
PMID: 16738152RESULTCommittee opinion no. 628: robotic surgery in gynecology. Obstet Gynecol. 2015 Mar;125(3):760-767. doi: 10.1097/01.AOG.0000461761.47981.07.
PMID: 25730256RESULTRafi AN. Abdominal field block: a new approach via the lumbar triangle. Anaesthesia. 2001 Oct;56(10):1024-6. doi: 10.1046/j.1365-2044.2001.02279-40.x. No abstract available.
PMID: 11576144RESULTYoung MJ, Gorlin AW, Modest VE, Quraishi SA. Clinical implications of the transversus abdominis plane block in adults. Anesthesiol Res Pract. 2012;2012:731645. doi: 10.1155/2012/731645. Epub 2012 Jan 19.
PMID: 22312327RESULTBhattacharjee S, Ray M, Ghose T, Maitra S, Layek A. Analgesic efficacy of transversus abdominis plane block in providing effective perioperative analgesia in patients undergoing total abdominal hysterectomy: A randomized controlled trial. J Anaesthesiol Clin Pharmacol. 2014 Jul;30(3):391-6. doi: 10.4103/0970-9185.137274.
PMID: 25190950RESULTAtim A, Bilgin F, Kilickaya O, Purtuloglu T, Alanbay I, Orhan ME, Kurt E. The efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing hysterectomy. Anaesth Intensive Care. 2011 Jul;39(4):630-4. doi: 10.1177/0310057X1103900415.
PMID: 21823381RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not know which type of injection they have received for pain control.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2018
First Posted
October 19, 2018
Study Start
January 27, 2016
Primary Completion
April 15, 2017
Study Completion
December 15, 2017
Last Updated
October 19, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share